Angiosoma Stock Market Value

GSTC Stock  USD 0.0001  0.00  0.00%   
AngioSoma's market value is the price at which a share of AngioSoma trades on a public exchange. It measures the collective expectations of AngioSoma investors about its performance. AngioSoma is trading at 1.0E-4 as of the 27th of July 2025, a No Change since the beginning of the trading day. The stock's open price was 1.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of AngioSoma and determine expected loss or profit from investing in AngioSoma over a given investment horizon. Check out AngioSoma Correlation, AngioSoma Volatility and AngioSoma Alpha and Beta module to complement your research on AngioSoma.
Symbol

Please note, there is a significant difference between AngioSoma's value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioSoma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioSoma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AngioSoma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AngioSoma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AngioSoma.
0.00
04/28/2025
No Change 0.00  0.0 
In 3 months and 1 day
07/27/2025
0.00
If you would invest  0.00  in AngioSoma on April 28, 2025 and sell it all today you would earn a total of 0.00 from holding AngioSoma or generate 0.0% return on investment in AngioSoma over 90 days. AngioSoma is related to or competes with NVIDIA, Microsoft, Apple, Amazon, Alphabet, Bristol Myers, and Meta Platforms. GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulatio... More

AngioSoma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AngioSoma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AngioSoma upside and downside potential and time the market with a certain degree of confidence.

AngioSoma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for AngioSoma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AngioSoma's standard deviation. In reality, there are many statistical measures that can use AngioSoma historical prices to predict the future AngioSoma's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AngioSoma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00016.30
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000866.30
Details
Naive
Forecast
LowNextHigh
0.0000020.00016.30
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

AngioSoma Backtested Returns

AngioSoma secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of standard deviation over the last 3 months. AngioSoma exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AngioSoma's mean deviation of 1.49, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.005, which signifies not very significant fluctuations relative to the market. As returns on the market increase, AngioSoma's returns are expected to increase less than the market. However, during the bear market, the loss of holding AngioSoma is expected to be smaller as well. At this point, AngioSoma has a negative expected return of -0.79%. Please make sure to confirm AngioSoma's coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and rate of daily change , to decide if AngioSoma performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.00  

No correlation between past and present

AngioSoma has no correlation between past and present. Overlapping area represents the amount of predictability between AngioSoma time series from 28th of April 2025 to 12th of June 2025 and 12th of June 2025 to 27th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AngioSoma price movement. The serial correlation of 0.0 indicates that just 0.0% of current AngioSoma price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test0.64
Residual Average0.0
Price Variance0.0

AngioSoma lagged returns against current returns

Autocorrelation, which is AngioSoma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AngioSoma's pink sheet expected returns. We can calculate the autocorrelation of AngioSoma returns to help us make a trade decision. For example, suppose you find that AngioSoma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

AngioSoma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AngioSoma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AngioSoma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AngioSoma pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

AngioSoma Lagged Returns

When evaluating AngioSoma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AngioSoma pink sheet have on its future price. AngioSoma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AngioSoma autocorrelation shows the relationship between AngioSoma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in AngioSoma.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in AngioSoma Pink Sheet

AngioSoma financial ratios help investors to determine whether AngioSoma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AngioSoma with respect to the benefits of owning AngioSoma security.